Position in LXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$420,374,548
+$178,988,998 QoQ
Shares Held
175,156,062
+13.2% QoQ
Ownership
39.4%
of shares outstanding
% of Portfolio
45.15%
of 13F equity value
Holder Rank
#1
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Artal Group S.A. holds $420,374,548 across 1 Biotechnology name. LXRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LXRX |
Lexicon Pharmaceuticals, Inc.
This page
|
175,156,062 | $420,374,548 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420,374,548 | 175,156,062 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $241,385,550 | 154,734,327 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $156,607,553 | 136,180,481 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $183,843,649 | 136,180,481 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $129,371,456 | 136,180,481 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $62,643,021 | 136,180,481 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $100,773,555 | 136,180,481 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $213,803,355 | 136,180,481 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $294,166,964 | 175,099,384 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $282,127,881 | 117,553,284 | Shares | Defined | 2024-05-17 | |
| 2023-12-31 | $179,856,524 | 117,553,284 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $128,133,079 | 117,553,284 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $269,197,020 | 117,553,284 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $218,161,108 | 89,778,234 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $171,476,426 | 89,778,234 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $215,467,761 | 89,778,234 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $132,391,757 | 71,178,364 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $148,762,780 | 71,178,364 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $280,442,754 | 71,178,364 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $342,367,930 | 71,178,364 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $326,708,690 | 71,178,364 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $417,816,996 | 71,178,364 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $243,430,004 | 71,178,364 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $86,746,844 | 60,240,864 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $120,481,728 | 60,240,864 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $117,469,684 | 60,240,864 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||